Synthetic Psilocybin Shows Strong Results in Treatment-Resistant Depression Trials
By
vinni2
Looks the part, but the middle's still raw. Chew with caution.
Summary
Compass Pathways, a British biotech company, announced strong results from two late-stage trials showing that a synthetic form of psilocybin (the active compound in magic mushrooms) can rapidly relieve symptoms in patients with treatment-resistant depression. The FDA is now reviewing the results, and if approved early next year, this would be the first psychedelic drug to become an approved medicine, validating years of biotech investment in psychedelic substances.
Key quotes
· 3 pulledOne of them may have hit the jackpot.
Compass Pathways, a British biotech, announced strong results in two late-stage trials showing that a synthetic form of psilocybin—the active compound in magic mushrooms—can rapidly relieve symptoms in patients with treatment-resistant depression (TRD).
If America's Food and Drug Administration (FDA) approves the drug, which could happen early next year, it would be the first psychedelic drug to become
You might also wanna read
Eli Lilly's experimental gene-editing therapy VERVE-102 shows promise as one-time treatment for high cholesterol
Eli Lilly is testing VERVE-102, an experimental gene-editing therapy for high cholesterol that could be administered as a one-time infusion
abcnews.com·3d ago
2026 Regeneron ISEF finalists apply biochemistry and AI to address the mental health crisis
This article highlights how 2026 Regeneron ISEF finalists are using biochemistry, AI, and medical research to develop solutions for the ment
societyforscience.org·4d ago
How the CircaVent project aims to destigmatize mental health and advance brain research
An interview with Matthew Woodworth about the CircaVent project at the Wyss Institute, which aims to destigmatize mental health issues and d
wyss.harvard.edu·4d ago
A Framework for Implementing Family-Focused Mental Health Care
This Viewpoint article outlines a framework for implementing family-focused mental health care, emphasizing the need to address mental healt
doi.org·5d ago
Decades of sleep physiology research at University of Toronto leads to new sleep apnea drug showing promise in Phase 3 trial
A University of Toronto professor's decades-long research on the physiology of sleep and breathing has led to a new drug treatment for sleep
temertymedicine.utoronto.ca·9d ago
Study Shows Youth Suicide Rates Declined After 988 National Hotline Implementation
A new study found that youth suicide rates in the United States dropped 11% below projections in the two and a half years following the 2022
nytimes.com·1mo ago